Adenylosuccinate lyase enzyme is essential for growth of endocrine therapy resistant ER plus breast cancer cells

被引:0
|
作者
Yadav, Anil K.
Clarke, Robert
Sengupta, Surojeet
机构
关键词
D O I
10.1158/1538-7445.AM2023-391
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
391
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Adenylosuccinate lyase is essential for proliferation and mitochondrial function of endocrine therapy resistant breast cancer cells
    Yadav, Anil
    Jin, Lu
    Clarke, Robert
    Sengupta, Surojeet
    CANCER RESEARCH, 2024, 84 (09)
  • [2] Ablation of adenylosuccinate lyase retarded the cell proliferation and induces mitochondrial dysfunction in endocrine therapy resistant breast cancer cells
    Yadav, Anil Kumar
    Jin, Lu
    Clarke, Robert
    Sengupta, Surojeet
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Genome-Directed Therapeutics for Endocrine Therapy Resistant ER plus Breast Cancer
    Ellis, Matthew J.
    CANCER RESEARCH, 2015, 75
  • [4] Cancer cells subvert fibroblast function to promote a growth factor enriched tumor microenvironment in endocrine therapy resistant ER plus breast cancer
    Griffiths, Jason I.
    Cosgrove, Patrick A.
    Castaneda, Eric Medina
    Nath, Aritro
    Chen, Jinfeng
    Adler, Frederick R.
    Chang, Jeffrey T.
    Khan, Qamar J.
    Bild, Andrea H.
    CANCER RESEARCH, 2023, 83 (07)
  • [5] PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
    Koichi Ito
    Sun Hee Park
    Igor Katsyv
    Weijia Zhang
    Carmine De Angelis
    Rachel Schiff
    Hanna Y. Irie
    npj Breast Cancer, 3
  • [6] PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
    Ito, Koichi
    Park, Sun Hee
    Katsyv, Igor
    Zhang, Weijia
    De Angelis, Carmine
    Schiff, Rachel
    Irie, Hanna Y.
    NPJ BREAST CANCER, 2017, 3
  • [7] Increasing DAXX Expression in ER plus Breast Cancer Cells to Overcome Endocrine Therapy Resistance
    Osipo, Clodia
    Albain, Kathy S.
    Peiffer, Daniel
    Wyatt, Debra
    CANCER RESEARCH, 2023, 83 (05)
  • [8] Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER plus Breast Cancer Cells
    Castellaro, Andres M.
    Rodriguez-Baili, Maria C.
    Di Tada, Cecilia E.
    Gil, German A.
    CANCERS, 2019, 11 (02)
  • [9] Notch signaling in ER plus breast cancer in response to endocrine therapy agents
    Singleton, Ciera S.
    Miele, Lucio
    Crabtree, Judy S.
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Lessons for ER plus breast cancer from neoadjuvant endocrine therapy trials
    Ellis, Matthew J.
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 18 - 18